FDA NDC Directory · JSON-LD · Markdown
NDC 59651-812 · HUMAN PRESCRIPTION DRUG · CAPSULE
| Labeler / Manufacturer | Aurobindo Pharma Limited |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA218949 |
| Dosage form / route | CAPSULE · ORAL |
| Active ingredients | ICOSAPENT ETHYL (1 g/1) |
| Marketing started | 20260624 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).